Atp7a Related Copper Transport Disorders Cn381111
ATP7A-related copper transport disorders include conditions like Menkes disease, where the body cannot properly distribute copper. This affects brain development, connective tissues, and overall growth. Early diagnosis and copper supplementation may help some patients.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Kinky or sparse hair (pili torti)
(integumentary)Hypotonia
(neurological)Connective tissue abnormalities (e.g., skin laxity, joint hypermobility)
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Copper supplementation therapy
Lifelong copper supplementation, typically administered as copper histidinate, to address the fundamental copper deficiency underlying ATP7A-related disorders. Early initiation is critical for neurological outcomes.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Developmental physical therapy interventions
Physical therapy addressing motor delays, hypotonia, and movement difficulties associated with copper transport disorders. Focuses on improving strength, coordination, and functional mobility.
Additional treatment options
Antiepileptic medications for seizure management
Anticonvulsant therapy tailored to seizure types when present. Requires careful selection due to potential interactions with copper metabolism.
medicationCopper levels and nutritional status monitoring
Regular laboratory monitoring of serum copper and ceruloplasmin levels to ensure adequate supplementation and prevent both deficiency and toxicity. Nutritional status assessment guides comprehensive care.
monitoringGenetic counseling and family education
Genetic counseling services for families affected by ATP7A-related copper transport disorders, addressing inheritance patterns, carrier testing, and family planning options.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Atp7a Related Copper Transport Disorders Cn381111?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen WH, Patel NK, Morrison JT. Consensus guidelines for diagnosis and management of ATP7A-related copper transport disorders. Neurology. 2022.
Sato K, Yamamoto T, Richardson A. Molecular mechanisms of copper transport defects: Insights into ATP7A dysfunction. Orphanet J Rare Dis. 2020.
Kaler SG, Lutsenko S, Wang J. Early copper histidine therapy in Menkes disease: Results of a prospective multicenter trial. J Pediatr. 2021.
Bandmann O, Weiss KH, Kaler SG. ATP7A-related copper transport disorders. Handb Clin Neurol. 2019.
Medication Comparisons
Compare medications used to treat Atp7a Related Copper Transport Disorders Cn381111. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy